IFLR1000

Takeda Pharmaceutical $57 billion acquisition of Shire

25/1/2019
Public acquisition
Select tab

¥ 6.2 trillion

$ 57 billion

Completed

25/1/2019

Overview:

  • Takeda Pharmaceutical, the largest pharmaceutical company in Asia, has acquired Jersey-registered and Ireland-headquartered biopharmaceutical company, Shire, for ¥6.2 trillion ($57 billion), which is Japan's biggest-ever foreign takeover.

Jurisdictions:

Japan
Ireland

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
Davis Polk & Wardwell

Party: Shire (Target)

Lawyers: Daniel Brass, Edmond FitzGerald, George Bason Jr, John B Meade, William Chudd

Latham & Watkins

Party: JPMorgan Chase (Lender)

Linklaters

Party: Takeda Pharmaceutical (Acquirer)

Lawyers: Aisling Zarraga, Ian Callaghan, James Inglis

Mourant Ozannes

Party: Shire (Target)

Lawyer: Robert Hickling

Nagashima Ohno & Tsunematsu

Party: Shire (Target)

Nishimura & Asahi

Party: Takeda Pharmaceuticals (Acquirer)

Lawyers: Hiroko Shibata, Kentaro Sugimoto, Kohei Koikawa, Toshiyuki Nonaka, Tsuyoshi Ito, Yamato Nozawa, Yo Ota

Slaughter and May

Party: Shire (Target)

Lawyer: Matthew Tobin

Related deals